NALOXONE AGUETTANT

Medicinal product

(Invented) name

NALOXONE AGUETTANT

Active substance (s)

Naloksono hidrochloridas

Strength

400 µg/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

V03AB15, Naloxone

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2021-09-16

Date of renewal

Documents

1591_NALOXONE AGUETTANT_2022-04-05.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Ampulėje (1 ml) yra	1 ml
Naloksono hidrochloridas	400 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107243	93347	1093347	ampulė	1 ml N10		Receptinis	LT/L/21/1591/001	Netiekiama	2025-06-11	-	No	-	-	Download

Stadijos

Data	Stadija
2021-09-16	Registruotas